Did the company raise or lower its full‑year 2025 guidance after releasing the Q2 results? | ONTO (Aug 07, 2025) | Candlesense
ONTO

Did the company raise or lower its full‑year 2025 guidance after releasing the Q2 results?

Answer:

Based on the excerpt you provided from Onto Innovation’s Q2 2025 results press release, the company does not mention any change to its full‑year 2025 guidance.

The only guidance‑related comment in the release is:

  • “Delivered a strong second quarter highlighted by revenue exceeding the midpoint of Onto’s previously announced guidance range.”

This statement tells us that Q2 revenue came in above the midpoint of the guidance the company had already given for the year, but the release does not say that the company raised or lowered its full‑year 2025 earnings or revenue outlook after publishing the results.

Conclusion:

There is no indication in the provided news that Onto Innovation altered (raised or lowered) its full‑year 2025 guidance after releasing the Q2 2025 results. If you need a definitive answer, you would need to consult the full press release or a subsequent company announcement that explicitly states a change (or lack thereof) to the full‑year guidance.

Other Questions About This News

What are the potential risks or headwinds mentioned that could affect future earnings? How did the market react to the earnings release (price movement, volume) and what is the implied sentiment? Is there any guidance on the timing and volume of future Dragonfly shipments? What was the reported EPS for the quarter and how does it compare to analyst expectations? Are there any updates on guidance for the upcoming Q3 and Q4 quarters? Did the company announce any changes to its capital allocation or share repurchase program? Did the company beat its revenue guidance for Q2 2025, and by how much? How did the performance of the Dragonfly® 3Di metrology tools contribute to revenue growth? How does Onto Innovation's Q2 margin and cash flow compare to the same quarter last year? What is the revenue split between the Dragonfly product line and other business segments? How does the company's Q2 performance compare with its primary competitors in the semiconductor metrology space? How does the reported guidance compare to analysts' consensus estimates for the fiscal year? What are the forward‑looking metrics (e.g., bookings, backlog) that support the outlook? What impact might the expanded Dragonfly footprint have on market share and pricing power?